You are here

Comment

Discuss

www.cb-association.org

STEM CELLS Translational Medicine is the official journal of the Cord Blood Association (CBA).

 

CBA Member Papers

Geraldine Dawson, Jessica M. Sun, Katherine S. Davlantis, Michael Murias, Lauren Franz, Jesse Troy, Ryan Simmons, Maura Sabatos-DeVito, Rebecca Durham, Joanne Kurtzberg
Yong Zhao, Zhaoshun Jiang, Elias Delgado, Heng Li, Huimin Zhou, Wei Hu, Marcos Perez‐Basterrechea, Anna Janostakova, Qidong Tan, Jing Wang, et al
Joanne Kurtzberg, Anthony Atala

Clinical Trials: Cord Blood

Body: Conditions:   Acute Biphenotypic Leukemia;   Acute Lymphoblastic Leukemia in Remission;   Acute Myeloid Leukemia in Remission;   Blasts Under 10 Percent of Bone Marrow Nucleated Cells;   Blasts Under 5 Percent of Bone Marrow Nucleated Cells;   Chronic Myelogenous Leukemia, BCR-ABL1 Positive;   Cytogenetic Abnormality;   High Risk Myelodysplastic Syndrome;   Myelodysplastic Syndrome With Excess Blasts;   Pancytopenia;   Refractory Anemia
Interventions:   Drug: Cyclophosphamide;   Drug: Fludarabine;   Other: Laboratory Biomarker Analysis;   Drug: Thiotepa;   Radiation: Total-Body Irradiation;   Biological: Umbilical Cord Blood-derived Hematopoietic CD34-positive Progenitor Cells;   Procedure: Umbilical Cord Blood Transplantation
Sponsors:   Fred Hutchinson Cancer Research Center;   National Cancer Institute (NCI);   National Heart, Lung, and Blood Institute (NHLBI)
Not yet recruiting
Body: Conditions:   Myelodysplastic Syndromes;   Leukemia, Myeloid, Acute;   Leukemia, Relapsed Adult Acute Myeloid;   Myelodysplastic Syndromes, Previously Treated
Interventions:   Drug: CPX-351;   Drug: Fludarabine;   Drug: Melphalan;   Drug: Rabbit Anti-Human T-Lymphocyte Globulin;   Biological: Haplo-Cord Stem Cell Transplantation
Sponsor:   Weill Medical College of Cornell University
Recruiting
Body: Condition:   Severe Bronchopulmonary Dysplasia
Interventions:   Biological: PNEUMOSTEM;   Other: Placebo
Sponsor:   Medipost Co Ltd.
Not yet recruiting
Body: Conditions:   Diabetes Mellitus, Type 1;   Diabetes Mellitus, Type 2
Intervention:   Combination Product: Stem Cell Educator therapy
Sponsors:   Tianhe Stem Cell Biotechnologies Inc.;   Chinese PLA General Hospital
Recruiting